[1]Zhang W, Zeng Ysh, Zhang XB, et al.Research on bone marrow mesenchymai stem cells modified by NT-3 gene and pretreated with retinoic acid to differentiate into neuron-like cells in the injured site of spinal cord[J]. Acta Anatomica Sinica, 2008(1):12-17.(in Chinese)
张巍,曾园山,张雪宝,等. NT-3基因修饰及维甲酸预诱导的骨髓间充质干细胞在脊髓损伤处分化为神经元样细胞的研究[J]. 解剖学报, 2008(1):12-17.
[2]Lu HX, Hao ZM, Jiao Q, et al. Neurotrophin-3 gene transduction of mouse neural stem cells promotes proliferation and neuronal differentiation in organotypic hippocampal slice cultures[J]. Med Sci Monit, 2011,17(11):R305-R311.
[3]Blais M, Levesque P, Bellenfant S, et al. Nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and glial-derived neurotrophic factor enhance angiogenesis in a tissue-engineered in vitro model[J]. Tissue Eng Part A, 2013,19(15-16):1655-1664.
[4]Cristofaro B, Stone OA, Caporali A, et al. Neurotrophin-3 is a novel angiogenic factor capable of therapeutic neovascularization in a mouse model of limb ischemia[J]. Arterioscler Thromb Vasc Biol, 2010,30(6):1143-1150.
[5]Hu Y, Liu J, Huang H. Recent agents targeting HIF-1alpha for cancer therapy[J]. J Cell Biochem, 2013,114(3):498-509.
[6]Shi Q, Zhang P, Zhang J, et al. Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice[J]. Neurosci Lett, 2009,465(3):220-225.
[7]Kim HA, Lim S, Moon HH, et al. Hypoxia-inducible vascular endothelial growth factor gene therapy using the oxygen-dependent degradation domain in myocardial ischemia[J]. Pharm Res, 2010,27(10):2075-2084.
[8]Shibata T, Giaccia AJ, Brown JM. Development of a hypoxia-responsive vector for tumor-specific gene therapy[J]. Gene Ther, 2000,7(6):493-498.
[9]Su H, Kan YW. Adeno-associated viral vector-delivered hypoxia-inducible gene expression in ischemic hearts[J]. Methods Mol Biol, 2007,366:331-342.
[10]Hu HW, Li XK, Zheng RY, et al. bFGF expression mediated by a hypoxia-regulated adenoviral vector protects PC12 cell death induced by serum deprivation[J]. Biochem Biophys Res Commun, 2009,390(1):115-120.
[11]Huang D, Desbois A, Hou ST. A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons[J]. Gene Ther, 2005,12(18):1369-1376.
[12]Shen F, Su H, Fan Y, et al. Adeno-associated viral-vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice[J]. Stroke, 2006,37(10):2601-2606.
[13]Westerink RH, Ewing AG. The PC12 cell as model for neurosecretion[J]. Acta Physiol (Oxf), 2008,192(2):273-285.
[14]Fu X, Shi ZhY, Jing HX, et al. Effect of hyppocampal microenvironment on cells’ differentiation and polarity[J].Acta Anatomica Sinica, 2013(05):586-593. (in Chinese)
符星,石贞玉,金海啸,等. 海马微环境对细胞分化和极性化的影响[J]. 解剖学报, 2013(05):586-593.
[15]Hillion JA, Takahashi K, Maric D, et al. Development of an ischemic tolerance model in a PC12 cell line[J]. J Cereb Blood Flow Metab, 2005,25(2):154-162.
[16]Lin CD, Kao MC, Tsai MH, et al. Transient ischemia/hypoxia enhances gentamicin ototoxicity via caspase-dependent cell death pathway[J]. Lab Invest, 2011,91(7):1092-1106.
[17]Chen W, Liu L, Luo Y, et al. Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cells[J]. Cancer Prev Res (Phila), 2012, 5(5) :778-787. |